Advertisement
Screener

Vir Biotechnology, Inc. (VIR) Auditor

Vir Biotechnology, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-23: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-02-26: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-232025-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2025-02-272024-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2024-02-262023-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2023-02-282022-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2022-02-282021-12-31Ernst & Young LLP42Redwood City, CaliforniaYes
2021-02-252020-12-31Ernst & Young LLPRedwood City, CaliforniaYes
2020-03-262019-12-31Ernst & Young LLPRedwood City, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40